“We are very encouraged by the outcome of our End-of-Phase 2 meeting and the constructive feedback supporting our planned Phase 3 trial for canvuparatide,” said Sam Azoulay, M.D., Chief Medical ...

Medium skin tones span a wide band, from golden‑beige to honey to tan‑olive. What ties them together is that they sit between light and deep tones but can lean warm, cool, or neutral. Because medium ...

The CellTolerance® Test ends years of trial-and-error diets by pinpointing food intolerances through live cellular imaging For millions of Americans suffering from ...

Nathan brings decades of experience in computational and AI-driven discovery. He joins Optibrium from Healx, where, as Director of Digital Chemistry, he led the development of AI-powered computational ...

In this ever-changing healthcare landscape, prioritizing data-driven decision-making and proactively adopting advanced technologies will position health systems to achieve lasting success in 2026 and ...

Supira Medical, Inc. (Supira), a clinical-stage company focused on transforming the percutaneous ventricular assist device (pVAD) market, today announced FDA approval to initiate the SUPPORT II ...

This strategic acquisition enhances Vygon’s leadership in vascular access and supports its ambition to accelerate growth in the United States, where extended-dwell catheters represent a significant ...

Eureka α utilizes state-of-the-art AI to analyze real-time video from laparoscopic and robotic surgery, enhancing surgeons' accuracy by highlighting the dissection planes characterized by connective ...

Innovaderm, a leading clinical research organization (CRO), is excited to reveal a major rebranding to Indero, with immediate effect. The new brand identity reinforces the company’s dual focus on ...

CE Marking and ARCH clinical trial data position the Liverty™ TIPS Stent Graft to expand treatment options for patients with advanced liver disease BD (Becton, Dickinson and Company) (NYSE: BDX), a ...

16.3.25. Zenith Sales & Calibrations Pty Ltd.

The study is designed to compare genicular artery embolization (GAE) with Nexsphere-F™ to intra-articular corticosteroid injections, with the primary goal of assessing both safety and efficacy in ...